These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22003984)

  • 21. Identification of ligands for RNA targets via structure-based virtual screening: HIV-1 TAR.
    Filikov AV; Mohan V; Vickers TA; Griffey RH; Cook PD; Abagyan RA; James TL
    J Comput Aided Mol Des; 2000 Aug; 14(6):593-610. PubMed ID: 10921774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding sites of the viral RNA element TAR and of TAR mutants for various peptide ligands, probed with LILBID: a new laser mass spectrometry.
    Morgner N; Barth HD; Brutschy B; Scheffer U; Breitung S; Göbel M
    J Am Soc Mass Spectrom; 2008 Nov; 19(11):1600-11. PubMed ID: 18693035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
    Long KS; Crothers DM
    Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA as a target for drug design, the example of Tat-TAR interaction.
    Froeyen M; Herdewijn P
    Curr Top Med Chem; 2002 Oct; 2(10):1123-45. PubMed ID: 12173971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
    Xie B; Calabro V; Wainberg MA; Frankel AD
    J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design-Based Peptidomimetic Ligand Discovery to Target HIV TAR RNA Using Comparative Analysis of Different Docking Methods.
    Fu J; Xia A; Dai Y; Qi X
    Curr HIV Res; 2016; 14(6):476-483. PubMed ID: 27450546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
    Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation.
    Vrolijk MM; Harwig A; Berkhout B; Das AT
    Retrovirology; 2009 Feb; 6():13. PubMed ID: 19210761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.
    Bernacchi S; Henriet S; Dumas P; Paillart JC; Marquet R
    J Biol Chem; 2007 Sep; 282(36):26361-8. PubMed ID: 17609216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
    Aboul-ela F; Karn J; Varani G
    J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the 5' TAR stem--loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA.
    Song R; Kafaie J; Laughrea M
    Biochemistry; 2008 Mar; 47(10):3283-93. PubMed ID: 18278873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic ensemble view of the conformational landscape of HIV-1 TAR RNA and allosteric recognition.
    Lu J; Kadakkuzha BM; Zhao L; Fan M; Qi X; Xia T
    Biochemistry; 2011 Jun; 50(22):5042-57. PubMed ID: 21553929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragment based search for small molecule inhibitors of HIV-1 Tat-TAR.
    Zeiger M; Stark S; Kalden E; Ackermann B; Ferner J; Scheffer U; Shoja-Bazargani F; Erdel V; Schwalbe H; Göbel MW
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5576-5580. PubMed ID: 25466178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
    Yang M
    Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attenuating HIV Tat/TAR-mediated protein expression by exploring the side chain length of positively charged residues.
    Wu CH; Chen YP; Liu SL; Chien FC; Mou CY; Cheng RP
    Org Biomol Chem; 2015 Dec; 13(45):11096-104. PubMed ID: 26399751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop.
    Erard M; Barker DG; Amalric F; Jeang KT; Gatignol A
    J Mol Biol; 1998 Jun; 279(5):1085-99. PubMed ID: 9642086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 Tat peptide binding to TAR RNA by electrospray ionization mass spectrometry.
    Sannes-Lowery KA; Hu P; Mack DP; Mei HY; Loo JA
    Anal Chem; 1997 Dec; 69(24):5130-5. PubMed ID: 9414617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape.
    Bardaro MF; Shajani Z; Patora-Komisarska K; Robinson JA; Varani G
    Nucleic Acids Res; 2009 Apr; 37(5):1529-40. PubMed ID: 19139066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
    Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
    Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A human chromosome 12-associated 83-kilodalton cellular protein specifically binds to the loop region of human immunodeficiency virus type 1 trans-activation response element RNA.
    Hart CE; Saltrelli MJ; Galphin JC; Schochetman G
    J Virol; 1995 Oct; 69(10):6593-9. PubMed ID: 7666565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.